DefronzoRA, FerranniniE, KowistoV. New concepts in the pathogenesis and treatment of noninsulin dependent diabetes mellitus.Am J Med1983; 1: 5281.
2.
CerasiE, LuftR, EfendiS. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose response study.Diabetes1972; 21: 22443.
3.
OlefskyJM, ReavenGM. Insulin binding in diabetes. Relationship with plasma insulin levels and insulin sensitivity.Diabetes1977; 26: 6808.
4.
OlefskyJM. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.J Clin Invest1976; 57: 116572.
5.
MccalebML, MaloffBL, NowakSMSulfonylurea effects on target tissue for insulin.Diabetes Care1986; 7(suppl 1): 426.
6.
KoltermanOG, GrayRS, GriffinJ. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus.J Clin Invest1981; 68: 95769.
7.
GroopL, HarnoK, TolppanenEM. The combination of insulin and sulfonylurea in the treatment of secondary drug failure in patients with type II diabetes.Acta Endocrinol1984; 106: 97101.
8.
OseiK, O'DORISIOTM, FalkoJM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.Am J Med1984; 77: 10029.
9.
Titus AllenB, FeinglosMN, LebovitzHE. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin sulfonylurea.Arch Intern Med1985; 145: 19003.
10.
LongneckerMP, ElsenhansVD, LeimanSMInsulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus.Arch Intern Med1986; 146: 6736.
11.
SchadeDS, MitchellWJ, GriegoG. Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes.JAMA1987; 257: 24415.
